IL-6 activates STAT3 to promote tumor initiation and growth67 and drives Fos-related antigen 1(FOSL1/ FRA1) deacetylation, endowing CRC cells with stem cell-like properties and enhancing their proliferation68. This evidence concerns the gene FOSL1 and colorectal carcinoma.